Emanuela M Ghia

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Chronic Lymphocytic Leukemia

Combination Therapy

Cell Cycle Arrest

Tyrosine Kinase

Top Venues

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Barbara A Parker, Rebecca A Shatsky, Richard B Schwab, Anne M Wallace, null null, Denise M Wolf, Gillian L Hirst, Lamorna Brown-Swigart, Laura J Esserman, Laura J van 't Veer, Emanuela M Ghia, Christina Yau, Thomas J Kipps
Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial. Breast cancer research and treatment (2023)
Emanuela M Ghia, Laura Z Rassenti, Michael Y Choi, Miguel Quijada-Álamo, Elvin Chu, George F Widhopf, Thomas J Kipps
High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia. Leukemia 36 (6) (2022)
Md Kamrul Hasan, Emanuela M Ghia, Laura Z Rassenti, George F Widhopf, Thomas J Kipps
Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism. Leukemia 35 (6) (2020)
Emanuela M Ghia, Laura Z Rassenti, Donna S Neuberg, Alejandro Blanco, Fouad Yousif, Erin N Smith, John D McPherson, Thomas J Hudson, null null, Olivier Harismendy, Kelly A Frazer, Thomas J Kipps
Activation of hedgehog signaling associates with early disease progression in chronic lymphocytic leukemia. Blood 133 (25) (2019)